Vilevev MB
VILEVEV MB Tablets
Approved
Approval ID
02f19c91-9d39-4843-b6a4-25d81280b067
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 21, 2019
Manufacturers
FDA
Vilvet Pharmaceuticals Inc
DUNS: 080444356
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
METHENAMINE, PHENYL SALICYLATE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, METHYLENE BLUE ANHYDROUS, and HYOSCYAMINE SULFATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71186-000
Product Classification
G
Generic Name
METHENAMINE, PHENYL SALICYLATE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, METHYLENE BLUE ANHYDROUS, and HYOSCYAMINE SULFATE
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 21, 2019
FDA Product Classification
INGREDIENTS (5)
PHENYL SALICYLATEActive
Quantity: 32.4 mg in 1 1
Code: 28A37T47QO
Classification: ACTIB
METHENAMINEActive
Quantity: 81 mg in 1 1
Code: J50OIX95QV
Classification: ACTIB
METHYLENE BLUE ANHYDROUSActive
Quantity: 10.8 mg in 1 1
Code: 8NAP7826UB
Classification: ACTIR
HYOSCYAMINE SULFATEActive
Quantity: 0.12 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSActive
Quantity: 40.8 mg in 1 1
Code: KH7I04HPUU
Classification: ACTIB